Loading chat...
ID S1346
Bill
Status
2/26/2026
Primary Sponsor
Judiciary and Rules Committee
Click for details
AI Summary
-
Establishes a 2-year moratorium prohibiting administration of human gene therapy products for infectious disease prevention to children under 18 and pregnant women in Idaho
-
Defines human gene therapy products as those working through transcription/translation of genetic material, including nucleic acids, genetically modified microorganisms, genome editing tools, and modified human cells
-
Exempts gene therapy products used for cancer treatment or genetic disorders from the moratorium
-
Allows exemptions for products the legislature determines have proven safety data, proper informed consent, and manufacturer compensation assurance for adverse outcomes
-
Permits continued use of gene therapy products in clinical trials under institutional review board protocols or through compassionate use for serious/life-threatening conditions
Legislative Description
Adds to existing law to establish a moratorium on certain uses of human gene therapy products.
IMMUNIZATIONS
Last Action
Reported out of committee; to 14th Order for amendment
3/5/2026